| Health Care Technology Industry | Healthcare Sector | - CEO | JPX Exchange | JP3806600007 ISIN |
| China Country | 239 Employees | 27 May 2026 Last Dividend | - Last Split | - IPO Date |
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., established in 1994 and headquartered in Shanghai, China, operates as an investment holding company with a global reach in the medical technology sector. The company is deeply engaged in the research, development, manufacture, and commercialization of interventional medical devices, offering advanced solutions for the treatment of various cardiovascular and congenital heart conditions. As a subsidiary of Lepu Medical Technology (Beijing) Co., Ltd., LEPU ScienTech has carved a niche for itself by specializing in an array of interventional medical devices that cater to the needs of hospitals and distributors worldwide.
LEPU ScienTech provides a comprehensive range of products designed for the treatment of congenital heart diseases. This includes occluder products for atrial septal defects, ventricular septal defects, and patent ductus arteriosus. Additionally, the company offers specialized delivery systems and snare products to support the deployment of these treatments.
The company’s portfolio includes left atrial appendage and patent foramen ovale occluder products, aimed at preventing strokes that may be caused by blood clots originating from the heart. These products are crucial for patients at risk of cardioembolic strokes, providing an effective preventive measure.
Offering a range of products for the treatment of valvular diseases, LEPU ScienTech has developed solutions for aortic, mitral, tricuspid, and pulmonary valve conditions. These include various valve products and procedural accessories essential for the successful treatment of valve-related heart diseases.
The company also manufactures vascular plugs and interatrial shunt devices, which are used to control abnormal blood flow within the heart or between blood vessels. These innovative devices are crucial for patients needing precise management of their blood flow to prevent or treat various cardiovascular conditions.